Assembly Bill A9893

2017-2018 Legislative Session

Relates to enhancing pharmaceutical transparency and consumer protection

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2017-A9893 (ACTIVE) - Details

See Senate Version of this Bill:
S7191
Current Committee:
Assembly Insurance
Law Section:
Public Health Law
Laws Affected:
Add §280-c, Pub Health L; amd §§3217-b & 4325, Ins L

2017-A9893 (ACTIVE) - Summary

Relates to enhancing pharmaceutical transparency and consumer protection between pharmacies and pharmacy benefit managers.

2017-A9893 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   9893
 
                           I N  A S S E M B L Y
 
                             February 20, 2018
                                ___________
 
 Introduced by M. of A. BRINDISI -- read once and referred to the Commit-
   tee on Insurance
 
 AN ACT to amend the public health law and the insurance law, in relation
   to contracts between pharmacies and pharmacy benefit managers
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. The public health law is amended by adding  a  new  section
 280-c to read as follows:
   §  280-C.  CONTRACTS BETWEEN PHARMACIES AND PHARMACY BENEFIT MANAGERS.
 1. ON AND AFTER JANUARY FIRST, TWO THOUSAND NINETEEN,  NO  CONTRACT  FOR
 PHARMACY  SERVICES  ENTERED INTO IN THE STATE BETWEEN A HEALTH INSURANCE
 CARRIER OR A PHARMACY BENEFIT MANAGER, AS DEFINED IN SECTION TWO HUNDRED
 EIGHTY-A OF THIS ARTICLE, AND A PHARMACY,  PHARMACIST  OR  A  PHARMACY'S
 CONTRACTING  AGENT, SUCH AS A PHARMACY SERVICES ADMINISTRATIVE ORGANIZA-
 TION, SHALL CONTAIN A PROVISION  PROHIBITING  OR  PENALIZING,  INCLUDING
 THROUGH  INCREASED  UTILIZATION REVIEW, REDUCED PAYMENTS OR OTHER FINAN-
 CIAL DISINCENTIVES, A PHARMACIST'S DISCLOSURE TO AN INDIVIDUAL  PURCHAS-
 ING PRESCRIPTION MEDICATION OF INFORMATION REGARDING (A) THE COST OF THE
 PRESCRIPTION  MEDICATION  TO  THE INDIVIDUAL, OR (B) THE AVAILABILITY OF
 ANY THERAPEUTICALLY EQUIVALENT ALTERNATIVE  MEDICATIONS  OR  ALTERNATIVE
 METHODS  OF  PURCHASING  THE PRESCRIPTION MEDICATION, INCLUDING, BUT NOT
 LIMITED TO, PAYING A CASH PRICE, THAT ARE LESS EXPENSIVE THAN  THE  COST
 OF THE PRESCRIPTION MEDICATION TO THE INDIVIDUAL.
   2. ON AND AFTER JANUARY FIRST, TWO THOUSAND NINETEEN, NO HEALTH INSUR-
 ANCE  CARRIER OR PHARMACY BENEFIT MANAGER SHALL REQUIRE AN INDIVIDUAL TO
 MAKE A PAYMENT AT THE POINT OF SALE FOR A COVERED  PRESCRIPTION  MEDICA-
 TION  IN  AN AMOUNT GREATER THAN THE LESSER OF (A) THE APPLICABLE COPAY-
 MENT FOR SUCH PRESCRIPTION MEDICATION, (B) THE  ALLOWABLE  CLAIM  AMOUNT
 FOR  THE  PRESCRIPTION MEDICATION, OR (C) THE AMOUNT AN INDIVIDUAL WOULD
 PAY FOR THE PRESCRIPTION MEDICATION  IF  THE  INDIVIDUAL  PURCHASED  THE
 PRESCRIPTION MEDICATION WITHOUT USING A HEALTH BENEFIT PLAN OR ANY OTHER
 SOURCE  OF  PRESCRIPTION  MEDICATION  BENEFITS  OR  DISCOUNTS.  FOR  THE
 PURPOSES OF THIS SECTION, "ALLOWABLE CLAIM AMOUNT" MEANS THE AMOUNT  THE
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.